Search Results - "Hourfar, M. K."

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 by Roth, W. K., Busch, M. P., Schuller, A., Ismay, S., Cheng, A., Seed, C. R., Jungbauer, C., Minsk, P. M., Sondag-Thull, D., Wendel, S., Levi, J. E., Fearon, M., Delage, G., Xie, Y., Jukic′, I., Turek, P., Ullum, H., Tefanova, V., Tilk, M., Reimal, R., Castren, J., Naukkarinen, M., Assal, A., Jork, C., Hourfar, M. K., Michel, P., Offergeld, R., Pichl, L., Schmidt, M., Schottstedt, V., Seifried, E., Wagner, F., Weber-Schehl, M., Politis, C., Lin, C. K., Tsoi, W. C., O'Riordan, J., Gottreich, A., Shinar, E., Yahalom, V., Velati, C., Satake, M., Sanad, N., Sisene, I., Bon, A. H., Koppelmann, M., Flanagan, P., Flesland, O., Brojer, E., Łętowska, M., Nascimento, F., Zhiburt, E., Chua, S. S., Teo, D., Stezinar, S. Levicnik, Vermeulen, M., Reddy, R., Park, Q., Castro, E., Eiras, A., Gonzales Fraile, I., Torres, P., Ekermo, B., Niederhauser, C., Chen, H., Oota, S., Brant, L. J., Eglin, R., Jarvis, L., Mohabir, L., Brodsky, J., Foster, G., Jennings, C., Notari, E., Stramer, S., Kessler, D., Hillyer, C., Kamel, H., Katz, L., Taylor, C., Panzer, S., Reesink, H.W.

Get full text

Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany by Sireis, W., Rüster, B., Daiss, C., Hourfar, M. K., Capalbo, G., Pfeiffer, H-U, Janetzko, K., Goebel, M., Kempf, V. A. J., Seifried, E., Schmidt, M.

“…Background  The Paul‐Ehrlich‐Institute analysed all fatalities due to bacterial infections between 1997 and 2007. Thereafter, the platelet shelf life was…”
Get full text

Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture by Müller, M. M., Fraile, M. I. G., Hourfar, M. K., Peris, L. B., Sireis, W., Rubin, M. G., López, E. M., Rodriguez, G. T., Seifried, E., Saldanha, J., Schmidt, M.

“…Background  The cobas® TaqScreen MPX Test, version 2.0, a multiplex, multi‐dye nucleic acid amplification technology (NAT) test from Roche was evaluated by two…”
Get full text

How to improve blood safety with respect to bacterial contaminations? by Sireis, W., Hourfar, M. K., Seifried, E., Schmidt, M.

Get full text

Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment by Hourfar, M. K., Schmidt, M., Seifried, E., Roth, W. K.

“…Background and Objectives  Nucleic acid extraction still harbours the potential for improvements in automation and sensitivity of nucleic acid amplification…”
Get full text

Fluorescence quencher improves scansystem™ for rapid bacterial detection by Schmidt, M., Hourfar, M. K., Wahl, A., Nicol, S.-B., Montag, T., Roth, W. K., Seifried, E.

“…Background and Objectives  The optimized scansystem™ could detect contaminated platelet products within 24 h. However, the system's sensitivity was reduced by…”
Get full text

West Nile virus lineage 2 infection in a blood donor from Vienna, Austria, August 2014 by Jungbauer, C, Hourfar, M.K, Stiasny, K, Aberle, S.W, Cadar, D, Schmidt-Chanasit, J, Mayr, W.R

“…Highlights • Autochthonous West Nile virus infection in an Austrian blood donor. • First extended human WNV–RNA screening of ≈68,000 samples from Eastern…”
Get full text

Donor screening for agents of bioterror by Schmidt, M., Roth, W.K., Seifried, E., Hourfar, M.K.

Get full text

Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests by Schmidt, M., Nübling, C. M., Scheiblauer, H., Chudy, M., Walch, L. A., Seifried, E., Roth, W. K., Hourfar, M. K.

“…Background and Objectives  Since voluntary introduction of hepatitis B virus (HBV) minipool nucleic acid amplification technology (NAT) at the German Red…”
Get full text

Oxygen measurements in platelet fluids - a new non-invasive method to detect bacterial contaminations in platelets by Mueller, M. M., Hourfar, M. K., Huber, E., Sireis, W., Weichert, W., Seifried, E., Tonn, T., Schmidt, M.

“…Background: The residual risk for bacterial contamination in blood components especially in platelets is one to two orders of magnitude higher than for…”
Get full text

Sensitivity and specificity of Anti-HBc screening assays - which assay is best for blood donor screening? by HOURFAR, M. K., WALCH, L. A., GEUSENDAM, G., DENGLER, T., JANETZKO, K., GUBBE, K., FRANK, K., KARL, A., LÖHR, M., SIREIS, W., SEIFRIED, E., SCHMIDT, M.

“…Summary Compared to HIV and hepatitis C virus, the residual infectious risk of hepatitis B virus (HBV) posed by blood products is about 10 times higher. In…”
Get full text

Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes by Schmidt, M., Pichl, L., Jork, C., Hourfar, M. K., Schottstedt, V., Wagner, F. F., Seifried, E., Müller, T. H., Bux, J., Saldanha, J.

“…Background  In 1997 the German Red Cross (GRC) blood donor services introduced mini‐pool nucleic acid testing (NAT) for human immunodeficiency virus (HIV)‐1,…”
Get full text

FACS technology used in a new rapid bacterial detection method by Schmidt, M., Hourfar, M. K., Nicol, S.-B., Spengler, H.-P., Montag, T., Seifried, Erhard

“…summary Culture methods for bacterial detection (BacT/ALERT or Pall eBDS) are currently implemented in blood donor screening procedures in many countries…”
Get full text

Balance module allows consistent monitoring and documentation of the pooling process for nucleic acid amplification technology testing by Hourfar, M. K., Koller, M., Roth, W. K., Kehrli, R., Seifried, E., Schmidt, M.

“…Background and Aims  When performing minipool testing of blood donations for transfusion‐transmissible viruses, it is crucial to correctly dispense plasma from…”
Get full text

Comparison of Two Real-Time Quantitative Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus by HOURFAR, Michael K, ROTH, W. Kurt, SEIFRIED, Erhard, SCHMIDT, Michael

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Blood screening for influenza by Hourfar, Michael Kai, Themann, Anna, Eickmann, Markus, Puthavathana, Pilaipan, Laue, Thomas, Seifried, Erhard, Schmidt, Michael

“…Influenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a…”
Get full text

Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes: Multiplex NAT screening in blood donors by Schmidt, M., Pichl, L., Jork, C., Hourfar, M. K., Schottstedt, V., Wagner, F. F., Seifried, E., Müller, T. H., Bux, J., Saldanha, J.

Get full text

ORIGINAL PAPER: Balance module allows consistent monitoring and documentation of the pooling process for nucleic acid amplification technology testing by Hourfar, M K, Koller, M, Roth, W K, Kehrli, R, Seifried, E, Schmidt, M

“…When performing minipool testing of blood donations for transfusion-transmissible viruses, it is crucial to correctly dispense plasma from each donation into…”
Get full text

ORIGINAL PAPER: Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment by Hourfar, M K, Schmidt, M, Seifried, E, Roth, W K

“…Nucleic acid extraction still harbours the potential for improvements in automation and sensitivity of nucleic acid amplification technology (NAT) testing…”
Get full text

ORIGINAL PAPER: Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests by Schmidt, M, Nübling, C M, Scheiblauer, H, Chudy, M, Walch, L A, Seifried, E, Roth, W K, Hourfar, M K

“…Since voluntary introduction of hepatitis B virus (HBV) minipool nucleic acid amplification technology (NAT) at the German Red Cross, the expected residual…”
Get full text